The Impact of Anemia on Clinical Outcomes of Patients Above 80 Years Old Following Transcatheter Aortic Valve Replacement
Related Experiment Video
Updated: Aug 10, 2026

Upper-extremity Approach for Secondary Access in Transfemoral Transcatheter Aortic Valve Implantation
Published on: August 8, 2025
Besir Besir1, Carl Ammoury2, Alexander Egoavil2
1Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Abstract:
•Anemia is highly prevalent among very elderly patients undergoing transcatheter aortic valve replacement and is associated with a greater burden of cardiovascular and noncardiovascular comorbidities.•Baseline anemia is associated with worse long-term clinical outcomes after transcatheter aortic valve replacement, including increased mortality and heart failure rehospitalization.•The adverse prognostic impact of anemia persists in patients over 80 years, highlighting anemia as an important risk marker and potential therapeutic target in this population.
Related Concept Videos
Heart Failure III: Clinical Manifestations
Aortic Regurgitation III: Medical Management
Atherosclerosis III: Management
Aortic Regurgitation I: Introduction
Heart Failure II: Pathophysiology
Aortic Regurgitation IV: Nursing Management
